ArticleNeoplasia (New York, N.Y.)2014

Anti-Bv8 antibody and metronomic gemcitabine improve pancreatic adenocarcinoma treatment outcome following weekly gemcitabine therapy.

Erez Hasnis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.